COMMUNIQUÉS West-GlobeNewswire

Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
22/09/2026
– New data from the Phase 3 INDIGO open-label extension will include the longer-term flare protection and safety data of obexelimab in IgG4-RD – – Additional analyses will assess glucocorticoid-associated toxicity and [...]
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
22/09/2026
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
CorVel Expands Managed Care Connectivity with the CareMC® Extension for Guidewire ClaimCenter
22/09/2026
FORT WORTH, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management and healthcare solutions, today announced the availability of its Care MC Accelerator for [...]
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
22/09/2026
BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that [...]
Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer
22/09/2026
Dr. Vnuk brings substantial business and corporate development leadership experience from Sanofi, Blackstone, and Pfizer CAMBRIDGE, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a [...]
Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
22/09/2026
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY ) (“Cerenome” or the “Company”), announced today that it has signed an in-network provider [...]
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
22/09/2026
IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership to integrate the iLet [...]
Lymphatic Malformation Alliance (LMA) Meets with FDA Leadership to Elevate Awareness of Lymphatic Malformations and Advance the Urgent Need for Approved Treatments
22/09/2026
LMA brings patient and physician perspectives to FDA leadership to elevate awareness of lymphatic malformations Patient experience highlights the serious, lifelong burden and significant unmet need LMA calls for greater [...]
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
22/09/2026
Nes-Ziona, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced the termination of a [...]
Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity
22/09/2026
-- First targeted therapy approved in Canada for patients four years and older living with acquired hypothalamic obesity (HO) -- BOSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a [...]
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
22/09/2026
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies for the treatment of hematologic [...]
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
22/09/2026
Patient screening for the Phase 2a study is expected to begin by the first quarter of 2027 Filana has engaged a leading clinical research organization, has identified clinical trial sites, and is recruiting potential [...]
Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
22/09/2026
Phase 1 study with ADG138 for patients with advanced solid tumors is expected to begin in China in the fourth quarter of 2026 ADG138 is a double-masked T-cell engager, applying Adagene’s proprietary SAFEbody® precision [...]
Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore
22/09/2026
Medera establishes Singapore laboratory and office to support human mini-heart cardiac disease modeling, drug discovery, and regional cardiovascular clinical innovation BOSTON and SINGAPORE, Sept. 22, 2026 (GLOBE [...]
Adventist Health Bakersfield Introduces Kern County’s First Next Generation Robotic-Assisted Bronchoscopy
22/09/2026
Advanced technology helps physicians detect lung cancer earlier and improve treatment BAKERSFIELD, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Kern County and surrounding areas now have access to a next-generation, [...]
Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to-Treat Cancers
22/09/2026
Envisagenics’ AI-powered SpliceCore ® platform opens up alternative RNA splicing – one of the last largely untapped sources of tumor-specific targets – for precision oncology Boehringer Ingelheim may apply selected [...]
Clene to Present at Upcoming Investor Conferences
22/09/2026
SALT LAKE CITY, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) today announced that management will participate at the 5 th Annual ROTH Healthcare Opportunities Conference and at the Lytham Partners [...]
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
22/09/2026
New director brings nephrology development expertise and over 30 years of experience in the biopharmaceutical industry JERSEY CITY, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or [...]
Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System
22/09/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with [...]

Pages